Risk prediction model based on blood biomarkers for predicting moderate to severe endoscopic activity in patients with ulcerative colitis

被引:5
|
作者
Li, Xiaojuan [1 ]
Tang, Zihui [2 ]
Liu, Yanbing [2 ]
Zhu, Xinyan [2 ]
Liu, Fei [2 ,3 ]
机构
[1] Fudan Univ, Minhang Hosp, Dept Gastroenterol, Shanghai, Peoples R China
[2] Tongji Univ, Shanghai East Hosp, Dept Gastroenterol, Med Sch, Shanghai, Peoples R China
[3] Jian Hosp, Shanghai East Hosp, Dept Gastroenterol, Jian, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
dynamic nomogram; Lasso regression; ulcerative colitis; endoscopic activity; blood biomarker; DISEASE; OUTCOMES; EVENTS; INDEX;
D O I
10.3389/fmed.2023.1101237
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectWe explored developing an internal validation model to predict the moderate to severe endoscopic activity of ulcerative colitis (UC) patients based on non-invasive or minimally-invasive parameters. MethodsUlcerative Colitis Endoscopic Index of Severity (UCEIS) and Mayo endoscopic subscore were performed for UC patients who met the criteria from January 2017 to August 2021 through the electronic database of our center. Logistic regression and a least absolute shrinkage and selection operator (Lasso) regression model were performed to screen the risk factors of moderate to severe UC activity. The nomogram was established subsequently. Discrimination of the model was evaluated using the concordance index (c-index), and the calibration plot and 1,000 Bootstrap were used to evaluate the model's performance and conduct internal validation. ResultsSixty-five UC patients were included in this study. According to UCEIS criteria,45 patients were moderate to severe endoscopic activity. 26 potential predictors of UC were analyzed by logistic and Lasso regression showed that vitamin D (Vit D), albumin (ALB), prealbumin (PAB), and fibrinogen (Fbg) were the best predictors of moderate to severe endoscopic activity of UC. We used these 4 variables to develop a dynamic nomogram prediction model. The c-index was 0.860, which means good discrimination. The calibration plot and Bootstrap analysis showed that the prediction model accurately distinguished the moderate to severe endoscopic activity in UC patients. The prediction model was verified using a cohort of UC patients with moderate to severe activity defined by the Mayo endoscopic subscore, and it was found that the model still had good discrimination and calibration (c-index = 0.891). ConclusionThe model containing Vit D, ALB, PAB, and Fbg was a good tool for evaluating UC activity. The model is simple, accessible, and user-friendly, which has broad application prospects in clinical practice.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] DISCORDANCE BETWEEN PATIENT-REPORTED SYMPTOMS AND ENDOSCOPIC MUCOSAL INFLAMMATION IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
    Hong, Ji Taek
    Moon, Chang Mo
    Shin, Jeong Eun
    Ye, Byong Duk
    Eun, Chang Soo
    Yoon, Soon Man
    Cha, Jae Myung
    Kim, You Sun
    Park, Young Soo
    Huh, Kyu Chan
    Park, Young-Sook
    Cheon, Jae Hee
    Jung, Eun Suk
    Kim, Youngdoe
    Jung, Su Young
    GASTROENTEROLOGY, 2022, 162 (07) : S1035 - S1036
  • [22] Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis patients
    Makoto Naganuma
    Hitoshi Ichikawa
    Nagamu Inoue
    Taku Kobayashi
    Susumu Okamoto
    Tadakazu Hisamatsu
    Takanori Kanai
    Haruhiko Ogata
    Yasushi Iwao
    Toshifumi Hibi
    Journal of Gastroenterology, 2010, 45 : 936 - 943
  • [23] Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis patients
    Naganuma, Makoto
    Ichikawa, Hitoshi
    Inoue, Nagamu
    Kobayashi, Taku
    Okamoto, Susumu
    Hisamatsu, Tadakazu
    Kanai, Takanori
    Ogata, Haruhiko
    Iwao, Yasushi
    Hibi, Toshifumi
    JOURNAL OF GASTROENTEROLOGY, 2010, 45 (09) : 936 - 943
  • [24] The Pharmacokinetics of Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis
    Brandse, Johannan F.
    van der Kleij, Desiree
    Wolbink, Gert-Jan
    Rigter, Irma M.
    Baars, Paul A.
    Lowenberg, M.
    Ponsioen, Cyriel
    Jansen, Jeroen M.
    van den Brink, Gijs R.
    Mathot, Ron A.
    D'Haens, Geert R.
    GASTROENTEROLOGY, 2014, 146 (05) : S134 - S134
  • [25] Exogenous Alkaline Phosphatase for the Treatment of Patients with Moderate to Severe Ulcerative Colitis
    Lukas, Milan
    Drastich, Pavel
    Konecny, Michal
    Gionchetti, Paolo
    Urban, Ondrej
    Cantoni, Franco
    Bortlik, Martin
    Duricova, Dana
    Bulitta, Michael
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (07) : 1180 - 1186
  • [26] Biologics for the treatment of moderate-to-severe ulcerative colitis in pediatric patients
    Albenberg, Lindsey G.
    Mamula, Petar
    Kelsen, Judith R.
    PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS, 2012, 3 : 51 - 58
  • [27] Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced Therapies
    Sands, Bruce E.
    D'Haens, Geert
    Panaccione, Remo
    Regueiro, Miguel
    Ghosh, Subrata
    Hudesman, David
    Ahmad, Harris A.
    Mehra, Dimpy
    Wu, Hsiuanlin
    Jain, Anjali
    Petersen, AnnKatrin
    Osterman, Mark T.
    Afzali, Anita
    Danese, Silvio
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (10) : 2084 - 2095
  • [28] PREDICTION OF OUTCOME IN ACUTE SEVERE ULCERATIVE COLITIS - COMPARISON OF CLINICAL AND ENDOSCOPIC INDICES
    Gupta, Vipin
    Mohsen, Waled
    Adams, Alex
    Murphy, Aisling
    Sathananthan, Dharshan
    Cripps, Sarah
    Brain, Oliver
    Palmer, Rebecca
    Ambrose, Tim
    George, Bruce
    Walsh, Alissa
    Travis, Simon
    Satsangi, Jack
    GUT, 2021, 70 : A96 - A97
  • [29] Comparison of three endoscopic scores for prediction of relapse risk in ulcerative colitis
    Horita, N.
    Saito, E.
    Motobayashi, M.
    Suzuki, K.
    Takenaka, K.
    Shimizu, H.
    Fujii, T.
    Nagahori, M.
    Ohtsuka, K.
    Watanabe, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S168 - S168
  • [30] Investigation of novel biomarkers for predicting the clinical course in patients with ulcerative colitis
    Hamanaka, Shinsaku
    Nakagawa, Tomoo
    Hiwasa, Takaki
    Ohta, Yuki
    Kasamatsu, Shingo
    Ishigami, Hideaki
    Taida, Takashi
    Okimoto, Kenichiro
    Saito, Keiko
    Maruoka, Daisuke
    Matsumura, Tomoaki
    Takizawa, Hirotaka
    Kashiwado, Koichi
    Kobayashi, Sohei
    Matsushita, Kazuyuki
    Matsubara, Hisahiro
    Katsuno, Tatsuro
    Arai, Makoto
    Kato, Naoya
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (12) : 1975 - 1983